Ratings Lepermislibre

Equities

ALLPL

FR001400F2Z1

Market Closed - Euronext Paris 08:29:58 31/05/2024 pm IST 5-day change 1st Jan Change
0.792 EUR +0.25% Intraday chart for Lepermislibre -17.33% -12.97%

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • The stock, which is currently worth 2023 to 0.45 times its sales, is clearly overvalued in comparison with peers.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

Ratings chart - Surperformance

Sector: Miscellaneous Educational Service Providers

1st Jan change Capi. Investor Rating ESG Refinitiv
-12.97% 10.42M -
+9.07% 13.23B
B-
-10.13% 7.25B
C-
+7.89% 4.18B
B
+15.65% 2.92B
C-
+22.79% 2.76B
C+
+14.22% 2.43B
C
+9.23% 2.42B
A-
+57.46% 1.48B
D+
+28.13% 1.48B
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes